Featured Articles

31. Applying The Four Dimensions Of Sustainability To Create Capacity That Delivers Results Faster

    There are no shortcuts to growing capacity that delivers results faster and maintaining it is difficult. The key ingredient in growing enterprise value is sustainability. Learn how by applying the principle of sustainability using its four dimensions, finite resources are more wisely used with extraordinary results, lead time from concept to commercialization is greatly improved, and patients receive better medications faster.

32. Meet The Scientist — Dr. Peng Zhang

    While pursuing a career as a medical doctor, Peng Zhang realized there were limited treatments for patients suffering from a variety of diseases. She made the decision to fill that void by focusing on discovering and developing therapeutics.

33. The Value Of Orphan Drug Designation

    More than 90% of rare diseases still have no FDA-approved treatment, even though rare diseases affect more than 25 million Americans. Despite the opportunities in the orphan drug market, there are challenges that may act as barriers to entry.

34. Meet Koshy George, Associate Director Of Manufacturing, Science And Technology

    Koshy George is a true Medicine Man. He knew as a young boy growing up in India that he wanted to make medicine.

35. Parenteral Drug Manufacturing — Innovation Begins With A Problem 6/11/2020

    Developing manufacturing processes for complex parenteral drug formulations often presents some of the most challenging problems—and innovative solutions —pharmaceutical scientists and engineers face.

36. Navigating An Ever-Changing Landscape: The Role Of A CFO In A Private Equity Controlled Pharma Company

    The role of Chief Financial Officer for a small-to-mid size pharma company controlled by private equity is a challenging one, especially since pharma companies with limited internal resources often rely on CDMOs for support. Learn how these CFOs can use their CDMOs to be more successful.

37. Oxygen Sensitive Drug Products

    Primary packaging is thought of as the first line of defense against the negative effects of oxygen. This article highlights other areas to consider that can help avoid drug quality degradation.

38. Vaccine Capacity Musical Chairs

    In the past six months, I’ve spoken to more vaccine developers than I have in the previous eight years, all of them searching for production capacity. Has the music stopped? Is it time to grab a chair?

39. Self-Injection Of Biologics Made Easy 6/17/2022

    Ready-to-Use (RTU) 3mL cartridge-based, single-use Pen Devices are specifically designed to ensure consistency of delivery for high-volume, high-viscosity injectable drug delivery systems.

40. Preventing Cross-Contamination – Operating Beyond cGMP

    One critical outcome universally accepted by the pharmaceutical industry is that cross-contamination of drug substances and products in manufacturing lines cannot occur. However, the conditions driving modern pharmaceutical development and manufacturing have increased the risk of cross-contamination.